枸橼酸西地那非治疗羊水过少:一项随机对照试验
这项开放标签随机试验纳入184例孕30周及以上特发性羊水过少单胎孕妇,比较口服枸橼酸西地那非(25 mg每8小时)联合静脉补液与单纯补液的效果。西地那非组最终羊水指数更高(11.5 cm vs 5.4 cm,P=.02),分娩孕周更晚(38.3周 vs 36.0周,P=.001),剖宫产率更低(28% vs 73%),新生儿入住新生儿重症监护室比例更低(11% vs 41%,P=.001)。
要点
- 西地那非组最终羊水指数为11.5 cm,补液组为5.4 cm(P=.02)。
- 西地那非组分娩孕周为38.3周,补液组为36.0周(P=.001)。
- 西地那非组剖宫产率为28%,补液组为73%;新生儿重症监护室入住率分别为11%和41%(P=.001)。
核心结论
- 枸橼酸西地那非可增加羊水过少妊娠的羊水量。
研究设计与样本
- 开放标签随机对照试验,纳入孕30周及以上特发性羊水过少(羊水指数小于5 cm、无母胎病因且胎儿生长正常)的单胎孕妇。
- 2015年2月24日至2016年4月,筛查196例,随机184例,完成随访166例(90%),其中西地那非组82例、补液组84例。
- 西地那非组口服枸橼酸西地那非25 mg每8小时联合静脉输注2 L等渗溶液直至分娩,补液组仅补液。
- 主要结局为随访6周时或分娩前最终羊水量(以先发生者为准);次要结局为妊娠延长时长、分娩方式及选定新生儿结局。
- 按α=0.05、80%把握度、检测组间45%差异计算,需样本量167例。
主要发现
- 最终评估时西地那非组羊水量高于补液组(11.5 cm vs 5.4 cm,P=.02)。
- 西地那非组分娩孕周晚于补液组(38.3周 vs 36.0周,P=.001)。
- 西地那非组剖宫产率低于补液组(28% vs 73%)。
- 西地那非组新生儿入住新生儿重症监护室比例低于补液组(11% vs 41%,P=.001)。
- 两组基线特征相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare sildenafil plus hydration with hydration alone in improving the amniotic fluid index and neonatal outcomes in pregnancies complicated by idiopathic oligohydramnios ( amniotic fluid index less than 5 cm without underlying maternal or fetal causes and with normal fetal growth). METHODS: This was an open-label randomized trial for women carrying singleton pregnancies at 30 weeks of gestation or more with idiopathic oligohydramnios detected during routine ultrasonogram. Women received either oral sildenafil citrate (25 mg every 8 hours) plus intravenous infusion of 2 L isotonic solution or fluids only until delivery. The primary study outcome was the amniotic fluid volume at 6 weeks of follow-up or the final volume before delivery, whichever occurred first. Secondary outcomes were duration of pregnancy prolongation, mode of delivery, and select neonatal outcomes. The study was powered to detect a 45% difference between groups, so, at an α level of 0.05 and 80% power, a sample size of 167 women was required. RESULTS: From February 24, 2015, through April 2016, 196 women were screened and 184 were randomized. Follow-up was completed in 166 (90%): 82 in the sildenafil group and 84 in the hydration group. Baseline characteristics were similar between groups. The amniotic fluid volume was higher in the sildenafil group at the final assessment (11.5 compared with 5.4 cm, P=.02). The sildenafil group delivered later (38.3 compared with 36.0 weeks of gestation, P=.001), had a lower rate of cesarean delivery (28% compared with 73%), and their neonates were less likely to be admitted to the neonatal intensive care unit (11% compared with 41%, P=.001). CONCLUSION: Sildenafil citrate increases amniotic fluid volume in pregnancies complicated by oligohydramnios. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT02372487.
引用
- Maher MA, Sayyed TM, Elkhouly N, et al. Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial. Obstet Gynecol. 2017. PMID: 28277352. doi:10.1097/AOG.0000000000001928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。